Merck & Co (MRK)
65.13
-0.47 -0.72%
NYSE
Sep 22, 20:00
Delayed 2m
USD
Merck & Co Shareholders Equity (Quarterly):
39.46B for June 30, 2017View 4,000+ financial data types
Browse...
View Full Chart
Merck & Co Shareholders Equity (Quarterly) Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Merck & Co Historical Shareholders Equity (Quarterly) Data
View and export this data going back to 1984.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| June 30, 2017 | 39.46B |
| March 31, 2017 | 39.84B |
| Dec. 31, 2016 | 40.09B |
| Sept. 30, 2016 | 43.74B |
| June 30, 2016 | 43.36B |
| March 31, 2016 | 43.81B |
| Dec. 31, 2015 | 44.68B |
| Sept. 30, 2015 | 45.59B |
| June 30, 2015 | 46.45B |
| March 31, 2015 | 47.76B |
| Dec. 31, 2014 | 48.65B |
| Sept. 30, 2014 | 45.22B |
| June 30, 2014 | 48.36B |
| March 31, 2014 | 49.98B |
| Dec. 31, 2013 | 49.76B |
| Sept. 30, 2013 | 47.42B |
| June 30, 2013 | 47.50B |
| March 31, 2013 | 53.03B |
| Dec. 31, 2012 | 53.02B |
| Sept. 30, 2012 | 55.75B |
| June 30, 2012 | 55.19B |
| March 31, 2012 | 54.86B |
| Dec. 31, 2011 | 54.52B |
| Sept. 30, 2011 | 55.14B |
| June 30, 2011 | 55.50B |
| March 31, 2011 | 54.38B |
| Dec. 31, 2010 | 54.38B |
| Sept. 30, 2010 | 55.59B |
| June 30, 2010 | 55.23B |
| March 31, 2010 | 57.88B |
| Dec. 31, 2009 | 59.06B |
| Sept. 30, 2009 | 22.91B |
| June 30, 2009 | 20.32B |
| March 31, 2009 | 19.56B |
| Dec. 31, 2008 | 18.76B |
| Sept. 30, 2008 | 19.57B |
| June 30, 2008 | 20.26B |
| March 31, 2008 | 19.52B |
| Dec. 31, 2007 | 18.18B |
| Sept. 30, 2007 | 20.72B |
| June 30, 2007 | 19.47B |
| March 31, 2007 | 18.48B |
| Dec. 31, 2006 | 17.56B |
| Sept. 30, 2006 | 19.29B |
| June 30, 2006 | 19.30B |
| March 31, 2006 | 18.85B |
| Dec. 31, 2005 | 17.98B |
| Sept. 30, 2005 | 17.78B |
| June 30, 2005 | 17.39B |
| March 31, 2005 | 17.65B |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Shareholders' Equity
Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More
Advertisement
MRK Shareholders Equity (Quarterly) Benchmarks
| Companies | |
|---|---|
| Abbott Laboratories | 31.60B |
| Celgene | 8.445B |
| Johnson & Johnson | 71.92B |
MRK Shareholders Equity (Quarterly) Range, Past 5 Years
| Minimum | 39.46B | Jun 2017 |
| Maximum | 55.75B | Sep 2012 |
| Average | 46.67B |
MRK Shareholders Equity (Quarterly) Excel Add-In Codes
- Metric Code: shareholders_equity
- Latest data point: =YCP("MRK", "shareholders_equity")
- Last 5 data points: =YCS("MRK", "shareholders_equity", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
MRK News
Drug Makers Stocks on Investors' Radar -- Alliqua BioMedical, Immune Pharma, Eli Lilly, and Merck
PR Newswire 09/22 07:05 ET
PR Newswire 09/22 07:05 ET
Advertisement
